Composition
- Active ingredients
- TERBINAFINE HYDROCHLORIDE EQ 125MG BASE/PACKET
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TERBINAFINE HYDROCHLORIDE 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CreamNDA020192-001 · Discontinued
- TERBINAFINE HYDROCHLORIDE 1% · SolutionNDA020749-001 · Discontinued
- TERBINAFINE HYDROCHLORIDE 1% · CreamNDA020980-001 · Over the counter
- TERBINAFINE HYDROCHLORIDE EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020539-001 · Discontinued
- TERBINAFINE HYDROCHLORIDE EQ 187.5MG BASE/PACKET · GranuleNDA022071-002 · Discontinued
- TERBINAFINE HYDROCHLORIDE EQ 125MG BASE/PACKET · GranuleThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022071.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamisil
- Active substance
- terbinafine hydrochloride
- Route
- Oral
- Dosage form
- Granule
- Applicant
- Novartis
- Status
- Discontinued
- FDA approval
- 28 Sept 2007
- Application
- NDA022071-001